Nvidia´s Push for a 100-Fold Increase in AI Computing Power

Nvidia´s CEO advocates for a significant expansion in Artificial Intelligence computing capacity.

Nvidia´s CEO, Jensen Huang, underscored the urgent necessity for a dramatic increase in Artificial Intelligence computing power during a recent announcement. He emphasized that the demand for AI technologies is soaring, necessitating a 100-fold boost in computing abilities to meet global needs. This surge in capacity is crucial not only for advancing AI applications but also for maintaining competitive edge in the rapidly evolving tech landscape.

In his address, Huang introduced the Rubin AI chips, which are designed to significantly enhance processing capabilities. These state-of-the-art chips reflect Nvidia’s commitment to pushing the boundaries of AI technology and to supporting industries in leveraging AI for innovative solutions. The announcement has received considerable attention, suggesting optimism among stakeholders concerning Nvidia´s strategic direction.

Further strengthening Nvidia´s position, the company has forged new corporate partnerships aimed at expanding its influence in the tech industry. Such collaborations are expected to foster innovation and provide robust frameworks for integrating AI solutions across various sectors, thereby contributing to the overall ecosystem´s growth and stability.

72

Impact Score

Crescent library brings privacy to digital identity systems

Crescent is a cryptographic library that adds unlinkability to common digital identity formats, preventing tracking across credential uses while preserving selective disclosure. It supports JSON Web Tokens and mobile driver’s licenses without requiring issuers to change their systems.

Artificial Intelligence-powered remote drug testing removes barriers to recovery

Q2i and King’s College London are collaborating to evaluate an Artificial Intelligence-powered at-home drug testing system aimed at people recovering from opioid use disorder. The solution delivers digitally observed, clinically reliable results and pairs testing with contingency management and telehealth to reduce logistical barriers to care.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.